Literature DB >> 3768362

Preparation and characterisation of liposomes containing mannosylated phospholipids capable of targetting drugs to macrophages.

G Barratt, J P Tenu, A Yapo, J F Petit.   

Abstract

We have prepared liposomes from mannosylated phosphatidylmyo-inositol, derived from mycobacteria, and cholesterol. The size of the particles so formed could be controlled by membrane filtration. The vesicles encapsulated a significant amount of aqueous phase (about 8 microliter per mg phospholipid). Markers of the liposomal membrane and aqueous phase rapidly associated with mouse peritoneal macrophages and, more slowly, with rat alveolar macrophages. The uptake was saturable at high liposome concentrations, although phagocytosis of latex particles of the same mean diameter was not saturable at these concentrations. An excess of unlabelled liposomes composed of phosphatidylcholine and phosphatidylserine, which were also taken up readily by macrophages, did not inhibit the uptake of mannosylated liposomes. The uptake of fluorescent mannosylated bovine serum albumin was inhibited by these liposomes, suggesting a specific interaction with the macrophage mannose-fucose receptor. We conclude that this type of liposome would be useful for the delivery of immunomodulators to reticuloendothelial cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768362     DOI: 10.1016/0005-2736(86)90479-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Dendritic cell delivery of plasmid DNA. Applications for controlled genetic immunization.

Authors:  R J Mumper; H C Ledebur
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

2.  Plasma factor triggering alternative complement pathway activation by liposomes.

Authors:  K Funato; C Yamashita; J Kamada; S Tominaga; H Kiwada
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

3.  Mannan-mediated gene delivery for cancer immunotherapy.

Authors:  Choon K Tang; Jodie Lodding; Gabriela Minigo; Dodie S Pouniotis; Magdalena Plebanski; Anja Scholzen; Ian F C McKenzie; Geoffrey A Pietersz; Vasso Apostolopoulos
Journal:  Immunology       Date:  2007-03       Impact factor: 7.397

4.  Influence of spacer length on interaction of mannosylated liposomes with human phagocytic cells.

Authors:  Andreas Engel; Swapan Kumar Chatterjee; Ali Al-arifi; Dagmar Riemann; Jürgen Langner; Peter Nuhn
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

5.  Activation of dendritic cells by liposomes prepared from phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette-Guerin and adjuvant activity in vivo.

Authors:  G Dennis Sprott; Chantal J Dicaire; Komal Gurnani; Subash Sad; Lakshmi Krishnan
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

6.  Glycyrrhetinic Acid Liposomes Containing Mannose-Diester Lauric Diacid-Cholesterol Conjugate Synthesized by Lipase-Catalytic Acylation for Liver-Specific Delivery.

Authors:  Jing Chen; Yuchao Chen; Yi Cheng; Youheng Gao
Journal:  Molecules       Date:  2017-09-24       Impact factor: 4.411

7.  Potential value of cetylmannoside-modified liposomes as carriers of macrophage activators to human blood monocytes.

Authors:  C Yamashita; S Sone; T Ogura; H Kiwada
Journal:  Jpn J Cancer Res       Date:  1991-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.